An 83-year-old man presented to our hospital with acute back pain. Vital signs were normal. Laboratory evaluation showed a normal leukocyte count and a C-reactive protein (CRP) of 0.6 mg/dL (range \<0.3). However, computed tomography revealed destruction of the Th7--Th8 vertebrae ([Fig. 1A](#F1){ref-type="fig"}), and magnetic resonance imaging showed an epidural lesion with anterior dural compression ([Fig. 1B](#F1){ref-type="fig"}). He had well-controlled type 2 diabetes mellitus with hemoglobin A1c up to 6.5% and had taken neither steroids nor immunosuppressive agents.

Histological evaluation of specimens obtained by needle biopsy confirmed necrosis and neutrophil infiltration (HE stain; [Fig. 2](#F2){ref-type="fig"}). Tuberculous spondylitis was diagnosed by a positive culture for *Mycobacterium tuberculosis* complex; unexpectedly, the interferon-gamma release assay (T-SPOT. TB) was negative. Detailed inquiries on his medical history revealed that 8 months previously, he suffered from severe systemic reaction after intrarenal Bacille Calmette-Guerin (BCG) therapy for upper tract urothelial carcinoma in situ (CIS). These findings were compatible with a disseminated BCG infection. Due to progressive weakness of the legs, he was referred to a specialized hospital for posterior spinal fusion and antituberculosis treatment.

BCG is an attenuated strain of *Mycobacterium bovis*. BCG therapy is considered to provoke local immunological responses. Intrarenal BCG is effective in the treatment of upper urinary tract CIS in a long-term follow-up.[@B1] Although BCG therapy is the gold standard of care for high-risk patients intolerant to resection, it can cause rare but serious complications, including sepsis, miliary tuberculosis and spondylitis.[@B2]

The timeframe for BCG spondylitis onset varies considerably (0.5 months--12 years).[@B2] Leukocyte counts are usually normal, and CRP levels are lower than those seen in pyogenic vertebral infections. In addition, T-SPOT.TB negative results are likely to indicate BCG infections with a deletion of region of difference 1 (RD1), which is present in the DNA of *M. tuberculosis* complex except with BCG.[@B2] BCG spondylitis should be considered in patients with back pain who have received BCG therapy, even when the treatment was performed several months to several years previously.[@B2]
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![(A) Computed tomography revealing destruction of the Th7--Th8 vertebrae. (B) Magnetic resonance imaging showing an epidural mass with anterior dural compression.](cmj-55-163-g001){#F1}

![Histological evaluation revealing necrosis and neutrophil infiltration.](cmj-55-163-g002){#F2}
